Nick Douglas is a clinical infectious diseases trainee and honorary post-doctoral research fellow in the Division of Global and Tropical Health at Menzies School of Health Research and at the School of Population and Global Health at the University of Melbourne. His PhD focused on haematological morbidity attributable to Plasmodium vivax malaria in Papua, Indonesia as well as the transmission dynamics and chemotherapeutic control of this parasite. Within ACREME, Nick will primarily be working on projects related to the safe and effective use of primaquine for radical cure of P. vivax malaria.Related Projects
Related Publications
- Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life
- Major burden of severe anemia from non-falciparum malaria species in southern Papua: A hospital-based surveillance study
- Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
- Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
- Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis.
- The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
- The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
- Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study